Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
biomarker
Press Release
Sep 21, 2022
Scailyte Closes Series A Funding With a CHF 6 Million Investment to Develop Strategic Partnerships in Immuno-Oncology
Read More
Press Release
Jul 12, 2022
Nilogen and Scailyte Are Joining Forces to Find the 'Right' Treatment for Every Patient
Read More
Press Release
Apr 19, 2022
Scailyte's 5th Anniversary Mini-Symposium - Machine Learning Meets Multi-Omics for Precision Medicine
Bringing industry and academia together to discuss the potential impact of single-cell analytics powered by machine learning for precision medicine.
Read More
Press Release
Apr 11, 2022
Scailyte AG Announces a Partnership With Sirona DX for AI-Driven End-Point Specific Single-Cell Analysis
Read More
Press Release
Feb 23, 2022
Scailyte Hosts Webinar About Supervised Learning of Disease-Associated Cell States and Dynamics
Webinar on the latest developments in the analysis of single-cell data, including from transcriptomic and imaging technologies.
Read More
Press Release
Jan 10, 2022
Scailyte Closes Financing Round and Onboards Top Biotech Leaders to Prepare for Growth in 2022
First closing of Series A round and onboarding of top biotech leaders to fuel growth in 2022
Read More
Press Release
Jul 5, 2021
Scailyte and Lexogen Create a Joint Biomarker Discovery Workflow for Precision Medicine Companies
Read More
Press Release
Jun 22, 2021
Scailyte Announces Michael Brenner, of Harvard Medical School, as an Advisor to Its Board of Directors
Read More
Press Release
Mar 29, 2021
Scailyte and Geninus Announce a Strategic Partnership to Develop a Predictive Assay for Immune-Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients
Read More
Press Release
Feb 24, 2021
Scailyte and Volv Global Announce Strategic Partnership to Accelerate Rare Disease Patient Diagnosis
Read More
Press Release
Sep 28, 2020
Vox Biomedical Receives NIH Award for Rapid COVID-19 Diagnostic Development
Read More
Press Release
Dec 18, 2019
A New Biomarker for Colorectal Cancer
Read More
Press Release
Oct 3, 2018
Biomarkers in NASH Drug Development: Using Cytokeratin 18 as a Secondary Endpoint in Clinical Trials, New Webinar Hosted by Xtalks
Read More
Press Release
May 4, 2018
New Cancer Test Improves Diagnosis of Prostate Cancer, Product Significantly Improves Diagnostics for Men's Health Care
Read More
Press Release
Apr 16, 2018
Overcoming the Challenges of Immuno-Oncology Biomarker Discovery: From Sample to Analytics, New Webinar Hosted by Xtalks
Read More
Press Release
Apr 11, 2018
Overcoming Bioanalytical Challenges in Drug Discovery and Biomarker Identification, New Webinar Hosted by Xtalks
Support of discovery programs is essential to providing integrated drug development services. The key is to have the expertise to be able to tackle complex matrices along with any biomarker component.
Read More
Press Release
Apr 5, 2018
Navigating the Complexities of NASH Development: Valuable Insights From a Key Opinion Leader, New Webinar Hosted by Xtalks
The race is on for non-alcoholic steatohepatitis (NASH) drug development as the disease—which has no approved treatments—is rapidly growing in prevalence and is the fastest rising cause of liver transplantation in the United States.
Read More
Press Release
Feb 27, 2018
Immunoprecipitation of Disease-Associated Proteins for Alzheimers' Research, New Webinar Hosted by Xtalks
Immunoprecipitation in combination with mass spectrometry is a powerful tool for studying disease-associated proteins
Read More
Press Release
Feb 20, 2018
Leveraging Key Biomarkers to Advance Immuno-Oncology Drug Development and Find the Right Trial Participants, New Webinar Hosted by Xtalks
Presented by Covance Chief Scientific Officer Steve Anderson, Ph.D., and Covance Global Leader, Precision Medicine and Head, Biomarker Solution Center, Suso Platero, Ph.D., this webinar will address the spectrum of immunotherapy development considerations and their implications for drug developers.
Read More
Press Release
Dec 10, 2015
NeuroQuest to Begin US Clinical Validation Trials for Alzheimer's Blood Test
NeuroQuest's blood-based biomarker test for early diagnosis of Alzheimer's disease exceeded U.S. Alzheimer's Association standards during recent pilot study in Australia. NeuroQuest has contracted with a major U.S. university to oversee collection and processing of 700 samples for their national clinical trial. The NeuroQuest blood test can potentially identify a pre-clinical stage of AD in a person years before the onset of noticeable symptoms, paving the way for new therapies and research.
Read More
Press Release
Jun 19, 2014
Pathology Diagnostics Ltd (PDL) Launches Social Media Presence Online
Having already established itself as one of the leaders in its industry, Pathology Diagnostics is continuing to grow from strength to strength - evolving into a formidable organisation within its market space. Wanting to showcase its employee experti
Read More
Press Release
Apr 4, 2014
Creodyne Acquires Exclusive Rights to Self-assembling DNA NanoBioSensor
Creodyne, LLC, announced today acquisition of intellectual property related to the design and implementation of a revolutionary nanoscale biosensing platform technology called the "Slider".
Read More
Press Release
Mar 21, 2011
Pacific Biomarkers Joins Fight To Curb Out-of-Control Spending On Diabetes Treatment
According to PBI, the major increase in the number of diagnosed cases of type 2 diabetes is the fastest-growing fraction in all age groups, and medical expenses for people with diabetes are more than two times higher than for people without diabetes.
Read More
Press Release
Mar 1, 2011
Pacific Biomarkers' Dr. Amar A. Sethi Recognized by R&D Directions as One of Nine "Most Notable People in R&D"
Vice President of R&D Singled Out For Work In Seeking Clues to Heart-Disease Risk
Read More
Press Release
Jan 11, 2011
Pacific Biomarkers, Inc. Announces Awards Of Major Research Contracts
Testing for the newly awarded contracts will begin as early as February 2011 and continue through the end of calendar 2011. PBI estimates the combined total revenue over the expected lives of these contracts at approximately $1.1 million.
Read More
Press Release
Jan 6, 2011
Pacific Biomarkers Comments on Study Regarding New Urine Test That Could Detect Acute Kidney Injury
Pacific Biomarkers has noted, with great interest, the publication of new studies suggesting that a simple urine test could help prevent cases of kidney failure.
Read More
First
Prev
1
Next
Last